Bayer's diabetes business sold to Panasonic for $1B
by
FRANKFURTJun 10, 2015 - 12:00 am GMT+3
by
Jun 10, 2015 12:00 am
German pharmaceuticals and chemicals giant Bayer said yesterday it has agreed to sell its diabetes care business to Panasonic Healthcare Holdings for 1.022 billion euros ($1.2 billion). "Bayer has entered into a definitive agreement to sell its Diabetes Care business to Panasonic Healthcare Holdings," which is 80-percent owned by US investor KKR and 20-percent by Panasonic Corporation, the German company said in a statement. The sale covers Bayer's portfolio of blood glucose monitoring meters and strips, as well as lancing devices. "Closing of the transaction is subject to customary conditions, including relevant antitrust clearance, and is expected to occur in the first quarter of 2016," Bayer said.
Keep up to date with what’s happening in Turkey,
it’s region and the world.
You can unsubscribe at any time. By signing up you are agreeing to our Terms of Use and Privacy Policy.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Please
click
to read our informative text prepared pursuant to the Law on the Protection of Personal Data No. 6698 and to get information about the
cookies
used on our website in accordance with the relevant legislation.
6698 sayılı Kişisel Verilerin Korunması Kanunu uyarınca hazırlanmış aydınlatma metnimizi okumak ve sitemizde ilgili mevzuata uygun olarak kullanılan
çerezlerle
ilgili bilgi almak için lütfen
tıklayınız.